Drug intelligence / Profile preview

Chewell

Development stage
Preclinical
Lead developer
Incannex Healthcare
Modality
Small Molecules
Administration
Oral
01

Overview

Chewell is a preclinical-stage small molecule cannabinoid composition developed by APIRx Pharma Sciences. The active ingredient is tetrahydrocannabivarin (THCV), a naturally occurring cannabinoid that interacts with the endocannabinoid system by targeting the CB1 and CB2 receptors. Unlike THC, THCV is often characterized as a CB1 receptor antagonist, which has led to research into its potential for metabolic and neurological applications. Chewell is currently part of APIRx's intellectual property portfolio with patent applications pending. The name suggests a formulation potentially designed for oral or buccal delivery, such as a medicated chewing gum, which aligns with the developer's specialized delivery platform technologies.

Brand names
Chewell
Other names
THCV compositiontetrahydrocannabivarin composition
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on Chewell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chewell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call